4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-24-000154
Director bought 10,000 shares at $1.09 ($10,900)
From the SEC's structured data for this filing
Trades in this filing
Jayasuriya Anula · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-29 | Purchase : show line 1 in the form | +10,000 | $1.09 | $10,900 | 10,000 | D |
| Open-market purchases · 10,000 sh · avg $1.09 · $10,900 | ||||||
Loading xslF345X05/ownership.xml…